Related Experiment Videos
Inhibition of thrombin-induced platelet aggregation by myristic acid
N Fukamachi1, Y Watanabe, B Kobayashi
1Department of Physiological Chemistry, School of Pharmaceutical Sciences, Kitasato University, Tokyo, Japan.
Abstract:
Myristate inhibited thrombin-induced aggregation and production of diacylglycerols of rabbit platelets suspended in a modified Tyrode solution. The incorporation of inositol into platelet phospholipids in both steady and activated states was also inhibited by myristate. When platelets were incubated with 32P-inorganic phosphate in the presence of myristate, incorporation of the radioactivity into platelet phosphatidylinositols (PI) was distinctly inhibited, although that into phosphatidic acid (PA) was inhibited relatively little. These results suggest that thrombin-induced breakdown of inositol phospholipids and the metabolic pathway of PA to PI are inhibited by myristate. The saturated fatty acids which have lower and higher molecular weight than myristate revealed a little or no inhibitory effects on the aggregation and on these metabolic changes of platelet lipids, suggesting the specificity of chain-length in the inhibitory action. It is conceivable that the inhibition of thrombin-induced aggregation by myristate is associated with the inhibition of PI-turnover in the platelets treated with the fatty acid.
Insights
Myristate, a fatty acid, inhibits platelet aggregation and key lipid metabolism pathways. This suggests myristate
Area of Science:
- Biochemistry
- Hematology
- Cell Biology
Background:
- Platelet aggregation is crucial for hemostasis and thrombosis.
- Phosphatidylinositol (PI) turnover plays a significant role in platelet activation.
- Fatty acids can modulate cellular processes, including platelet function.
Purpose of the Study:
- To investigate the effect of myristate on thrombin-induced platelet aggregation.
- To examine the impact of myristate on phospholipid metabolism in platelets.
- To determine the specificity of myristate's inhibitory action based on fatty acid chain length.
Main Methods:
- Rabbit platelets were suspended in a modified Tyrode solution.
- Platelet aggregation and diacylglycerol production were measured.
- Inositol incorporation into phospholipids and 32P-inorganic phosphate incorporation into PI and phosphatidic acid (PA) were analyzed.
Main Results:
- Myristate significantly inhibited thrombin-induced platelet aggregation and diacylglycerol production.
- Myristate reduced inositol incorporation into platelet phospholipids.
- Myristate specifically inhibited the incorporation of 32P into phosphatidylinositol (PI) more than phosphatidic acid (PA), suggesting inhibition of PI turnover.
Conclusions:
- Myristate inhibits thrombin-induced platelet aggregation.
- Myristate interferes with inositol phospholipid metabolism, particularly the breakdown of PI and the PA to PI pathway.
- The inhibitory effect of myristate on platelet function is likely due to its specific action on PI turnover.